戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 led all criteria for brain death, except the apnea test.
2  consistent with brain death and required an apnea test.
3 ss of central drive to breathe assessed with apnea test.
4  was declared dead following repeat negative apnea tests.
5 o 2 greater than 60 mm Hg by the end of both apnea tests.
6 es were measured every 2 minutes during both apnea tests.
7  is needed to confirm the benefits of HFO in apnea testing.
8 racheal tube is feasible and safe method for apnea testing.
9                                              Apnea test and repeat clinical examination after a durat
10 ails of the clinical examination, details of apnea testing, and details of ancillary testing.
11  all aspects of the clinical examination and apnea testing, and specifying appropriate ancillary test
12 dered breathing study including a home sleep apnea test (ApneaLink Plus).
13                                       If the apnea test cannot be safely completed, an ancillary stud
14 ath a) when components of the examination or apnea testing cannot be completed safely as a result of
15 th (a) when components of the examination or apnea testing cannot be completed safely due to the unde
16 use of HFO through the endotracheal tube for apnea testing compared with use of a T-piece in patients
17 ygen (HFO) through the endotracheal tube for apnea testing during brain death evaluation.
18    In recent years, a strategy of home sleep apnea testing followed by initiation of autotitrating co
19  +/- 118 mm Hg) but remained stable with HFO apnea test (from 342 +/- 114 to 308 +/- 92 mm Hg).
20 2 decreased significantly during the T-piece apnea test (from 404 +/- 115 to 215 +/- 118 mm Hg) but r
21  with confirmed brain death via the standard apnea test, HFO yielded consistent diagnostic results wh
22 were edited to simulate Level III home sleep apnea tests (HSAT) with the auto-scored AHI and ODI base
23    Fifteen patients underwent two successive apnea tests in the same order, each lasting 10 minutes:
24 otocol is provided for how to safely perform apnea testing, including modifications needed for patien
25                                              Apnea testing may be performed by the same physician.
26  report suggests that current guidelines for apnea testing may lead to erroneous evaluation of medull
27 d, and the second neurologic examination and apnea test (or all components that are able to be comple
28 ed and the second neurologic examination and apnea test (or all components that are able to be comple
29  are used, a second clinical examination and apnea test should be performed and components that can b
30  are used, a second clinical examination and apnea test should be performed, and components that can
31 nterfere with the neurologic examination and apnea testing should be discontinued allowing for adequa
32 nterfere with the neurologic examination and apnea testing should be discontinued allowing for adequa
33                                           4) Apnea testing to support the diagnosis of brain death mu
34                                          (4) Apnea testing to support the diagnosis of brain death mu
35 me order, each lasting 10 minutes: The first apnea test used 8 L/min of oxygen via a T-piece without
36                                   The second apnea test used HFO at 50 L/min and F io 2 of 1.0 throug
37                                           An apnea test was performed for 9 mins 23 secs, at which ti
38 ia for clinical brain death and requiring an apnea test were eligible.
39 tients, OSA can be diagnosed with home sleep apnea testing, which has a sensitivity of approximately
40               (3) Two examinations including apnea testing with each examination separated by an obse
41               3) Two examinations, including apnea testing with each examination separated by an obse